6 LEPROSY REVIEW
When the clinica.\ trial of sulphetrone was contempl ated, trial s wi th diason e ha d already been in progress for 12 months, an d in . vie w of the progress of pa ti en ts receivin g diason e, it was fel t desir able to provide ri goro us conditions fo r testing the ne w drug by selectin g the mo st un pro mi sin g cases that were available. The 17 cases con ce rne d were all lepromatous pa tients of varying degrees of se verity, some of them extremely heavily infected. They were cl assi fie d as follows
Advan ced nod ? la r or diff use leproma (Cases 4, 5, 7, IS) Mo derately advanced ditto (Cases I, 8, 10, II, I2, 16, 17) 4 7
Early or ' mild di tto 4 (some al so ex hibiting macules) (Cases 2, 6, 13, 14) Macula r lepromatous ca ses 2 (without no dules or obvio us diffuse infiltra ti on) (Cases 3, 9) All these patients ' had rec ei ve d treatment wi th hydno,carj ms oil in adeq uate dosage for v arying periods, ' three of them for more than 10 ye ars. In 7 cases the dise. ase wa s advancing rapidly, with a very ba d pro gno sis. In the remai nder the in fe ction ha d clinically been mor e or·less sta tiona ry fo r some ti me. These ci rcumstances provide the only fo rm of control possible in a trial of this nature. The· two ma cul ar cases were in cl uded fo r the sake of interest. All ca'ses were adul ts, but after experience wi th the drug th e experiment has recently been enlarged by the addition of 20 chil dren to ' the series of patients .
DOSAGE.
The drug is supplied in tablets of o. sgm, and therapy com men ced with one tabl et each' week' acco rding to toleran ce, up to a da il y do se of 3 gms, given on six days of the week. When this stan dar d daily do se was reached, wi thout toxi c signs, the drug was gi ven in co urses of si x weeks at this dosage, followed by two weeks re st. Al tho ugh th ere was so me in dividual variation , this do sage prov ed suitable and has been maintained. During the rest periods an d during parts of the course , patients al so re ceived ferr ous sulphate, gr. 3 b.d:
Observation s were ma de at suitable intervals througho ut the co urse of treatment of patients' weight, daily temperature range, urine , h<emo globin , E. S.R., and red and whi te bl oo d 'cell count� . A hypo chromjc an<el,lia develo p ed in 15 out of the 17 cases,. the decl ine in red cell count varying betwee n 100,000 and 800,000, with an averag e fall of 450,000. The lowest fig ures in individual patients' were reached between the second-and the sixth month of therapy, after' which tb e count tended to rise aga in, and in 9 ca ses it is now higher than at the start of the experiment. In all pa tients h<em oglobin percentage has remained in the nei ghbourhood of 60% . The white cell count has shown no significant variation. There has been no evidence whatever of kidney damag e. Patients ha ve not complained of nausea, vomiting or disturbances of vision. Headache has been expeii" enc ed by three' patients, but in only one of these could the suphetrone possibly be impl ica ted . Symptoms of lepra re action have appeared in three pa tients, in all ca ses mil d, and further reference will be mad e to these. The drug has proved to be relatively atoxic in the dosage employed. Bl ood concentration es .
CLINICAL PROGRESS.
In general cond ition every pa tient has improved . The weight has increased in 6, decrea sed in.7'
In dividual notes on the 17 pa tients are appended.
Of th e 17 cases reported on, 13 ha ve received sulphetrone for 10 months, I for 9 mont hs, 2 for 6 months, and one for 5i months.
They ha ve received no ot er anti-l eprosy treatment durin;g this time. No patient has become worse. In two there is little change, but all t4 e rest sh owed real and notabl e improvement, in 7 ca ses . the improvement. being very ma rked indeed , nodules becoming absorbed and infiltra tion diminishing. The improvement wa s pa rticul<!-rly striking in th e advan ced and degenerating cases, in all of wh om the outlook of the case ha s been en tirely transf ormed. In most ca ses Improvement was' apparent within th ree months of the first dose. -The progress of the series is summarised a follow s.
Grea Nil Th e ba cteriological findings have not followed the cl in ica l improvement. Th is is· not surprising, and has been discussed by Muir in rela tion to diasone th erapy (I). Nevertheless, two cases ... . h have become bacteriologically negative, and in 9 others , bacilli, formerly exceeding ly numerous, have diminishe ' d in rece nt te � ts , promising findings in view of th e relatively short period of trial, and th e type of case concerned . In th is respect sulphetrone com pares favourably with diasone, Although inost cases have improved steadily without inter ruption and without evidence of lepra' reaction, a few sh owed heigh tened sensitivity , to th e drug and care with dosage was . necessary. Case No. I is of particular interest. Here a lepro matous condition of marry years duration, ·already extensive and degenerating , began to improve , steadily during sulphetrone th erapy, until without warning and without constitutional symp toms, fi ve months after th e first dose, a papular exanthem appeared , the lesions of wh ich proved on biopsy to be atypically tuberculoid in nature, wh ile th e leprOl;nin reaction changed from negative 'to strongly positive. These lesions have tended slowly ' to subside and, although bacilli remain numerous in them, degenerating forms are frequent. Th e , ch ange ' from th e lepro matous to th e tuberculoid ph ase is an extremely rare phenomenon, and was probably influenced by th � sulphetronein this case. After some weeks rest sulphetrone was res timed in th is case on a standard ,dose of 2 gm daily. Th e further prog ress of this remarkable case will be of interest.
Another case' calling for comment ; is case No . . 6. . After four months th erapy this patient began to exhibit a succession of vesiculo-pustular' lesions on th e face, which discharged a bead of pus containing large numbers of degenerating bacilli, Th e patient at th is time began to be very sensitive to sulphetrone, doses in excess 6f I gm stimulating more of th ese lesions.
An increase above th is dose in the month of October resulted in an acute re action, with <:ed ema of th e face and a large number of large pustular lesions. On th e neck, limbs and ' trunk, wh eals and ' flat pink macular �reas appeared , ' Th e drug was ' discontinued and th ese rapidly disappeared , and th ree weeks later th e patient was very fit . . Th ere qas been marked clinical ' improvement in th is patien t, but close medical supervision is necessary. It is of interest t� note th at a precisely similar condition has arisen in a ch ild wh o recently commenced' sulphetrone th erapy, numerous vesicular lesions appearing within one month of starting the drug .
In case No: 10 al so, a macular eruption h as appeared, faint and poorly defined, becoming marked after 7 months of sulphetrone th erapy. , Th e re were no constitutio � al symptoms, but the macules ha ve persisted an d the bacteriological test ' has become negative. Th ere appears to be a tendency for the drug to stimulate a mild ' lepra reaction with th e appearance of ma cules. A similar tendency ha s been noted with diasone. It is of interest tha t" in II of the 17 ca ses, the . lepromin' test has chang ed from nega tive to positive. This aller; gising effect in some individuals ca lls for caref ul super vision of th e drug . weeks has been in a state of m ild lepra reac tion , w i th a s u ccessi o n of small pustules appearing on t he face, discharging a bead of pus c ontain i ng m an y lep r a bacilli, and healing almost without scars. Dosage of sulp h etron e has been cut o u t fo r a week , t h e n resu med , then cut o u t fo r a week. Improvement is most marked . Repo,.t. (I4/rr/47) . The mild leproma reaction reported in Jun e settled down leaving t he pat i e nt c on si d erably improved, but on ly sensitive to sulphetrone small d oses (1 gm . .l leading to recrudes_ ce nce of pustulation o n the fac e. He has continued interm itten t l y on this dose and, when increased in October , another reaction occurred more marked 'than i n June but hav ing he same charac teristics.
This has now settled down . Bacteriological test re m ains strongl y + ve i n skin but bacilli are not so numerous in the ea r . nepol·t.
(I4 / rr/4 7) . The patient is very fit a n d in recent tests bacilli are found to be fewer than formerly .. 
Male .
A ge 33.
Moderately advanced lepro matous case with erythe matou s lep rO'm ato us macules and diffuse infiltration of the face.
" years ' t reatm en t with hydnocarpus oil with some improvement.
Commenced sulphetrone 3/2/47.
Report.
(15/5/47) . 
